A Message from Our CEO Regarding COVID-19
Mark DiIanni 2020-01-09T12:06:24+00:00

Mark Di Ianni – Founder, Board Member, Chair of Advisory Board, Board of Directors

Mark Di Ianni is an experienced executive and “company builder”. He has worked for Pharmaceutical/Biotechnology product companies early and late career and has provided consulting services to the industry for over 30 years through the development and management of several independent Pharmaceutical Service firms.

Mr. Di Ianni’s senior management experience includes operations, business development and strategic planning on an international basis. Mr. Di Ianni started his pharmaceutical career at Roche pharmaceuticals and then entered the fledgling Contract Research Organization (CRO) industry when he joined Besselaar Associates where he was a principal. Besselaar became the “market maker” for a multi-billion dollar service industry. Mark has held P&L responsible positions as COO/EVP and Board Member of SCIREX, a CNS focused CRO, COO of SYNARC a company providing medical imaging services for clinical trials, and President of Early Stage Development at Pharmanet Development Group, a publically traded CRO. Mark retired from BioMarin, a products company for rare genetic diseases, in 2015 where he was a Group Vice President.

Mark holds a BS degree (Electrical Engineering) and BA degree (Psychology-experimental emphasis) from Lafayette College, and an MA (Psychology-experimental emphasis) from Fairleigh Dickinson University.